Complete Remission of Refractory, Ulcerated, Primary Cutaneous CD30+ Anaplastic Large Cell Lymphoma Following Brentuximab Vedotin Therapy

被引：10
|
作者：
Patsinakidis, Nikolaos [1 ]
Kreuter, Alexander [1 ]
Moritz, Rose K. C. [1 ]
Stuecker, Markus [1 ]
Moellenhoff, Katrin [1 ]
机构：
[1] Ruhr Univ Bochum, Dept Dermatol Venereol & Allergol, DE-44791 Bochum, Germany
来源：
ACTA DERMATO-VENEREOLOGICA | 2015年 / 95卷 / 02期
关键词：
LYMPHOPROLIFERATIVE DISORDERS; EORTC; ISCL;
D O I：
10.2340/00015555-1874
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：233 / 234
页数：2
相关论文
共 50 条
  • [1] Remission of refractory granulomatous primary cutaneous anaplastic large cell lymphoma to brentuximab vedotin
    Sasapu, Appalanaidu
    Dunn, Andrew L. J.
    Gardner, Jerad
    Wong, Henry K.
    BMJ CASE REPORTS, 2021, 14 (07)
  • [2] Complete remission of primary cutaneous anaplastic large cell lymphoma after a short course of brentuximab vedotin
    Milan, Elisa
    Miceli, Paola
    Sernicola, Alvise
    Finotto, Silvia
    Marino, Dario
    Alaibac, Mauro
    MOLECULAR AND CLINICAL ONCOLOGY, 2021, 14 (06)
  • [3] Brentuximab vedotin is an effective therapy for CD30+ mycosis fungoides and cutaneous anaplastic large-cell lymphoma: what is the cost?
    Scarisbrick, J. J.
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 (06) : 1474 - 1475
  • [4] PRIMARY CUTANEOUS ANAPLASTIC CD30+ LARGE CELL LYMPHOMA
    Marrero-Calvo, M. D.
    Rodriguez-Serna, M.
    Castejon-Calvete, P.
    Pelaez-Malagon, S.
    ACTAS DERMO-SIFILIOGRAFICAS, 2007, 98 (03): : 194 - 197
  • [5] Complete Remission of a CD30-positive large-cell anaplastic Lymphoma under Therapy with Brentuximab Vedotin (Adcetris®)
    Drescher, C.
    Mickler, M.
    Berneburg, M.
    Haferkamp, S.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2016, 14 : 17 - 17
  • [6] Brentuximab Vedotin in primary cutaneous CD30+large-cell anaplastic T-Cell Lymphoma
    Moritz, R. K. C.
    Patsinakidis, N.
    Terras, S.
    Moellenhoff, K.
    Gambichler, T.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 (09): : 921 - 921
  • [7] Remission of primary cutaneous anaplastic large cell lymphoma after a brief course of brentuximab vedotin
    Amrita Desai
    Gladys H. Telang
    Adam J. Olszewski
    Annals of Hematology, 2013, 92 : 567 - 568
  • [8] Remission of primary cutaneous anaplastic large cell lymphoma after a brief course of brentuximab vedotin
    Desai, Amrita
    Telang, Gladys H.
    Olszewski, Adam J.
    ANNALS OF HEMATOLOGY, 2013, 92 (04) : 567 - 568
  • [9] Complete response in a case of CD30+ primary cutaneous diffuse large B-cell lymphoma of the scalp treated with brentuximab vedotin
    Zhou, Xiaolong
    Garza, Mildreth Amelyn Cid
    Vega, Adriane
    Amini, Sadegh
    Ollague, Jose
    Ross, Andrew
    Alonso-Llamazares, Javier
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB157 - AB157
  • [10] Management of multifocal primary cutaneous CD30+ anaplastic large cell lymphoma
    Shehan, JM
    Kalaaji, AN
    Markovic, SN
    Ahmed, I
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 51 (01) : 103 - 110
12345